Cabot (CBT)
(Delayed Data from NYSE)
$93.38 USD
+0.66 (0.71%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $93.41 +0.03 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
Income Statements
Fiscal Year end for Cabot Corporation falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 3,931 | 4,321 | 3,409 | 2,614 | 3,337 |
Cost Of Goods | 3,092 | 3,436 | 2,610 | 2,114 | 2,652 |
Gross Profit | 839 | 885 | 799 | 500 | 685 |
Selling & Adminstrative & Depr. & Amort Expenses | 313 | 496 | 345 | 479 | 379 |
Income After Depreciation & Amortization | 526 | 389 | 454 | 21 | 306 |
Non-Operating Income | 15 | 2 | 1 | -1 | 8 |
Interest Expense | 90 | 56 | 49 | 53 | 59 |
Pretax Income | 451 | 335 | 406 | -33 | 255 |
Income Taxes | -28 | 102 | 123 | 191 | 70 |
Minority Interest | 39 | 34 | 36 | 17 | 29 |
Investment Gains/Losses | 5 | 10 | 3 | 3 | 1 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 484 | 243 | 286 | -221 | 186 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 445 | 209 | 250 | -238 | 157 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 670 | 535 | 614 | 179 | 454 |
Depreciation & Amortization (Cash Flow) | 144 | 146 | 160 | 158 | 148 |
Income After Depreciation & Amortization | 526 | 389 | 454 | 21 | 306 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 56.50 | 56.90 | 56.80 | 56.60 | 58.80 |
Diluted EPS Before Non-Recurring Items | 5.38 | 6.28 | 5.02 | 2.08 | 3.91 |
Diluted Net EPS (GAAP) | 7.73 | 3.62 | 4.34 | -4.21 | 2.63 |
Fiscal Year end for Cabot Corporation falls in the month of September.
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 958.00 | 965.00 | 968.00 | 1,033.00 |
Cost Of Goods | NA | 740.00 | 740.00 | 745.00 | 823.00 |
Gross Profit | NA | 218.00 | 225.00 | 223.00 | 210.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 82.00 | 83.00 | 73.00 | 81.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 136.00 | 142.00 | 150.00 | 129.00 |
Non-Operating Income | NA | -20.00 | 6.00 | 4.00 | 4.00 |
Interest Expense | NA | 22.00 | 21.00 | 24.00 | 23.00 |
Pretax Income | NA | 94.00 | 127.00 | 130.00 | 110.00 |
Income Taxes | NA | 34.00 | -118.00 | 41.00 | 29.00 |
Minority Interest | NA | 11.00 | 12.00 | 8.00 | 7.00 |
Investment Gains/Losses | NA | 1.00 | 1.00 | 1.00 | 1.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 61.00 | 246.00 | 90.00 | 82.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 50.00 | 234.00 | 82.00 | 75.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 55.80 | 56.10 | 56.50 | 56.80 |
Diluted EPS Before Non-Recurring Items | NA | 1.56 | 1.65 | 1.42 | 1.33 |
Diluted Net EPS (GAAP) | NA | 0.88 | 4.08 | 1.43 | 1.29 |